A new potential treatment agent called diphenyliodonium chloride has been observed to destroy cancerous stem cells and prevent their spread. This discovery has fewer harmful side effects than traditional chemotherapy methods.
Researchers report that diphenyliodonium chloride targets more than 90 protein enzymes – which provide energy production by feeding the mitochondria. Diphenyliodonium chloride attacks cancerous stem cells by creating a vitamin deficit, and also makes stem cells metabolically inflexible, thus increasing the sensitivity of cancerous cells to other drugs. Moreover, it does not cause harmful effects like chemotherapy and does not produce free radicals.
Researchers believe that this method is more beneficial than chemotherapy and is a promising treatment method that can be used instead of chemotherapy in the future.